24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The aggregate gross proceeds to the Company from the Offering are expected to be approximately $10.0 million, before deducting the placement agent fees and other offering expenses payable by the ...

Boston-based Elicio is studying ELI-002 as an adjuvant treatment for KRAS-mutated pancreatic ductal carcinoma patients ... Elicio's pipeline also includes two preclinical off-the-shelf therapeutic ...

In rare cases, hepatitis B can lead to life-threatening complications like liver failure, liver cancer, or cirrhosis (liver scarring). The hepatitis B vaccine is a shot, typically injected into the ...

However, immunohistochemical staining confirmed the diagnosis of high-grade serous ovarian carcinoma. Further analysis of NGS identified two novel missense mutations, D326E in BTK (Bruton’s tyrosine ...

During a Case-Based Roundtable® event, Chul Kim, MD, moderated a discussion on current use of ALK TKIs in lung cancer in the second article of a 2-part series.

The Chinese poultry lineage may have experienced more vaccine-driven selection compared ... more research is also needed to assess whether these mutations in HA have had an impact on the late ...